Anti-cancer immunotherapy using cancer-derived multiple epitope-peptides cocktail vaccination clinical studies in patients with refractory/persistent disease of uterine cervical cancer and ovarian cancer [phase 2]

Satoshi Takeuchi,Masahiro Kagabu,Tadahiro Shoji,Yukari Nitta,Toru Sugiyama,Junya Sato,Yusuke Nakamura

Anti-cancer immunotherapy using cancer-derived multiple epitope-peptides cocktail vaccination clinical studies in patients with refractory/persistent disease of uterine cervical cancer and ovarian cancer [phase 2]

2020

Satoshi Takeuchi
Masahiro Kagabu
Tadahiro Shoji
Yukari Nitta
Toru Sugiyama
Junya Sato
Yusuke Nakamura

We had conducted phase 1/2 studies of cancer vaccination therapy using neo-tumor antigens in patients with refractory/persistent cervical cancer (CC) and ovarian cancer (OC) to assess the feasibili...

Keywords:

Vaccination
Cancer
Ovarian cancer
Refractory
Oncology
Internal medicine
in patient
Epitope
Cancer immunotherapy
Persistent Disease
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations